Nasdaq biol.

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will be presenting at the Benchmark Company Discovery...

Nasdaq biol. Things To Know About Nasdaq biol.

Nov 22, 2023 · BIOL Biolase Inc Statement of Ownership (sc 13g) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction ... Biolase Inc (NASDAQ:BIOL) $1.165 -0.075 [-6.05%] Last update: 3:45PM (Delayed 15-Minutes) Get Real Time Here $1.17 0.0050 [0.43%] Profile News Analyst …The latest price target for . Biolase (NASDAQ: BIOL) was reported by Lake Street on May 31, 2023.The analyst firm set a price target for $0.40 expecting BIOL to fall to within 12 months (a .../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it received notification from the Listing Qualifications...FOOTHILL RANCH, Calif., April 20, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, and EdgeEndo, a global leader in commercializing endodontic products, announced in association with the American Association of Endodontists (AAE) Annual Meeting beginning on April 21, 2021, the co …

The BIOL share has a YTD performance of -22% and a 52-week price range of $0.37 - $10.4. The stock has experienced positive momentum due to a solid revenue report in Q4 2022. With a stock price below $1, the stock may provide great value to investors considering a positive outlook for 2023. Best place to buy BIOL: RobinhoodBIOL. Exchange. Nasdaq. Market Cap. 2.64m. Last Price. $1.15. 52-Week Range. $1.07 - $97.50. Stock Overview. 12/01/2023 03:59 PM EST. Investor Relations.

Biolase Inc (NASDAQ:BIOL) is the most popular stock in this table. On the other hand Gyrodyne, LLC (NASDAQ:GYRO) is the least popular one with only 1 bullish hedge fund positions. Just Energy ...

Jun 13, 2021 · Biolase Inc (NASDAQ:BIOL) is not the least popular stock in this group but hedge fund interest is still below average. Our overall hedge fund sentiment score for BIOL is 19.8. Stocks with higher ... NASDAQNYSEIBEX35LSEDAXCRYPTO. Buscar. NASDAQ:BIOL. BIOLASE Inc. Sector. Health. Industry. Medical supplies and equipment. 1,65 $ Last price. -0,03 $ VARIATION.BIOL Biolase Inc stock NASDAQ ... Shares Out. ... biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in ...Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.LAKE FOREST, Calif., March 6, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced plans to launch a second season of the popular podcast series ...

BIOL Biolase Inc BIOLASE, Inc to Report First Quarter 2022 Results on May 12, 2022

Real time Biolase (BIOL) stock price quote, stock graph, news & analysis.

LAKE FOREST, Calif., March 17, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for the fourth quarter and full year ...BIOL Biolase Inc stock NASDAQ ... Shares Out. ... biolase, inc. is a medical device company that develops, manufactures, markets, and sells laser systems in ...BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers.Dec 4, 2023 · Nelly Dodson. December 4, 2023. Technologies. Biolase Inc (NASDAQ:BIOL) has a beta value of 1.20 and has seen 1.07 million shares traded in the recent trading session. The company, currently valued at $3.29M, closed the recent trade at $1.43 per share which meant it gained $0.28 on the day or 24.35% during that session. Research BIOLASE's (Nasdaq:BIOL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios Screener

NASDAQ Stock BIOL Historical charts - Biolase, Inc. ... Indicator ADX is indicating that momentum is weak. Momentum is towards selling. ... Indicator RSI is ...BIOL. BIOLASE, Inc. 1.2400. +0.0200. +1.64%. BIOLASE, Inc. (NASDAQ:BIOL) Q4 2022 Earnings Call Transcript March 28, 2023 Operator: Greetings. Welcome to the BIOLASE 2022 Fourth Quarter and Full ...P/E & PEG Ratios. Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the ...Analyst Recommendations on BIOLASE, Inc. Biolase Files Registration Statement for Unit Offering at Target Price of $60 a Unit. Sep. 12. MT. Lake Street Adjusts Price Target on …BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with ...LAKE FOREST, Calif., Feb. 9, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that the Company has been awarded a Top Workplaces 2022 honor ...

/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it received notification from the Listing Qualifications...Analyst Recommendations on BIOLASE, Inc. Biolase Files Registration Statement for Unit Offering at Target Price of $60 a Unit. Sep. 12. MT. Lake Street Adjusts Price Target on …

FOOTHILL RANCH, Calif., Feb. 4, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, today received official notification from the Listing Qualifications Department ...BIOL Biolase Inc Form 8-K - Current report BIOLASE, INC false 0000811240 0000811240 2023-11-14 2023-11-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K ...Find the latest SEC Filings data for Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.Nov 8, 2023 · BIOL) stock’s latest price update. The stock price of Biolase Inc (NASDAQ: BIOL) has jumped by 6.01 compared to previous close of 1.58. Despite this, the company has seen a fall of -0.30% in its stock price over the last five trading days. IRVINE, Calif., June 8, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with ...May 15, 2021 · Spare a thought for those who held BIOLASE, Inc. (NASDAQ:BIOL) for five whole years - as the share price tanked 88%. Shareholders have had an even rougher run lately, with the share price down 46% ... Biolase (NASDAQ: BIOL) stock is surging more than 26% with heavy trading this morning. Biodexa Pharmaceuticals (NASDAQ: BDRX) shares are gaining over 19% as a prospectus goes into effect.IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a ...Track Biolase Inc (BIOL) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable ...

The company's shares jumped 32.6% to $3.46 in premarket trading. Tracon pharmaceuticals, inc.'s shares surged 116.9% after reporting better- than-expected sales. BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists ...

As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.

Find the latest news headlines from Biolase, Inc. Common Stock (BIOL) at Nasdaq.com.BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising business momentum for its market-leading dental lasers.Biolase, Inc. is estimated to report earnings on 11/09/2022. The upcoming earnings date is derived from an algorithm based on a company's historical reporting …On March 9th, the NASDAQ rallied up by around 4% during intraday trading. These gains were led by tech, as a large rebound occurred following a market correction over the past few weeks. Shares of ... BIOL shares climbed slightly on the announcement that the European Patent Office may give a specification to its Dual Pulse-Width Medical …IRVINE, Calif., July 9, 2020 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that BIOLASE CEO Todd Norbe has been invited to participate in a ...01 Mar, 2022, 16:15 ET. FOOTHILL RANCH, Calif., March 1, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the global leader in dental lasers, today announced that its Board of Directors ...BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release second quarter 2023 financial and operating results on Thursday, August 10, 2023, after the .../PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it will participate in the H.C. Wainwright BIOCONNECT Virtual...Gainers Zomedica Corp. (NYSE: ZOM) shares jumped 77.5% to $0.8591 after surging 21% on Friday. The company, last week, appointed Robert Cohen as Chief Executive Officer.(NASDAQ: BIOL), a global leader in dental lasers, today announced the appointment of Russell Morrow, D.D.S. as Chief Dental Officer ("CDO"), effective November 1, 2022. Dr. Samuel Low, who has served as Chief Dental Officer since 2016, will be taking on a new role as Vice President, Clinical Strategic Alliances, where he will focus on …Posted by Techdows on Nov 30th, 2023. StockNews.com lowered shares of BIOLASE ( NASDAQ:BIOL – Free Report) from a hold rating to a sell rating in a report issued on Wednesday. Separately, Benchmark cut their price objective on shares of BIOLASE from $10.00 to $4.00 in a research report on Wednesday, September 20th. Get BIOLASE alerts:Biolase Inc NASDAQ 1.090 -0.020 -1.80% After Hours: 1.130 +0.04 +3.67% 19:32 11/30 EST OPEN 1.140 PREV CLOSE 1.110 HIGH 1.180 LOW 1.071 VOLUME 237.58K …

LAKE FOREST, Calif., June 14, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that President and Chief Executive Officer, John Beaver and Chief Financial Officer, Jennifer Bright, have been invited to participate in the 2023 Virtual Healthcare Conference, presented by Maxim …/PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced its financial results for its third quarter ended September...Research BIOLASE's (Nasdaq:BIOL) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Dashboard Markets Discover Watchlist Portfolios ScreenerNov 24, 2021 · At just 47 cents a share, BIOL stock is in danger of being delisted by the Nasdaq, which requires companies to maintain a minimum share price of $1 to remain on the exchange. However, in a news ... Instagram:https://instagram. tqqq comparetarga 4 gts3 year treasury notereview fundrise Bio-Rad Laboratories, Inc. Class A Common Stock (BIO) Stock Price, Quote, News & History | Nasdaq. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p ... best home lenders in floridabest time to buy stock Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. crybf stock BIOLASE, Inc. (NASDAQ:BIOL) said its second-quarter revenues climbed 2.11% to $9.1 million. The company reported break-even results as opposed to the loss of 12 cents per share a year earlier. The ...Jul 26, 2023 · BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced that it held a special meeting of its stockholders on July 20, 2023 where the Company's ...